Fundz Deep Dive
Everything you need to win Elicio Therapeutics — in one platform.
Who to reach, what to say, and why now on Elicio Therapeutics — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Elicio Therapeutics — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering
Jun 28, 2024•almost 2 years ago
Contract Type
partnership
BostonBiotechnologyDescription
Elicio Therapeutics has announced the pricing of an approximately $11.5 million underwritten public offering of its common stock and accompanying common warrants. The offering is expected to close on or about July 1, 2024.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months